Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04881942 · ClinicalTrials.gov registry record · NA
Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users
A NA study, sponsored by Altria Client Services.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04881942: Completed NA study, sponsored by Altria Client Services.
NCT04881942 is a NA study that has completed, run by Altria Client Services. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04881942, a NA study, has completed, sponsored by Altria Client Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is an open-label, 4-way crossover study designed to estimate the nicotine, glycerin, propylene glycol, menthol, formaldehyde, acetaldehyde, and acrolein levels in exhaled breath samples during use of four MarkTen® XL e-vapor products. The study will enroll approximately 32 adult e-vapor-using subjects at one site in the United States in High Point, NC.
Primary Outcome
Table summarizes the amount of analyte present in exhaled breath after test product use. Analyte was collected over an approximately 10-min collection period in the exhaled breath product use session on day the subject was assigned the indicated test product according to the randomization scheme. In the exhaled breath test product use session, one exhaled breath sample was collected using an empty cartridge and inactive battery \[sham condition\] followed by an exhaled breath sample using the t
Interventions
- OTHER e-Vapor Product A
- OTHER e-Vapor Product B
- OTHER e-Vapor Product C
- OTHER e-Vapor Product D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-03-27 |
| Est. Completion | 2018-01-26 |
| Phase | NA |
What the finished NCT04881942 record still lists
NCT04881942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which e-Vapor Product A is the first listed.
NCT04881942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04881942 about?
NCT04881942 is a clinical study titled "Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users". This is an open-label, 4-way crossover study designed to estimate the nicotine, glycerin, propylene glycol, menthol, formaldehyde, acetaldehyde, and acrolein levels in exhaled breath samples during use of four MarkTen® XL e-vapor products. The study will enroll approximately 32 adult e-vapor-using s...
What is the current status of trial NCT04881942?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2017-03-27. Estimated completion is 2018-01-26.
What interventions are being tested in trial NCT04881942?
The interventions under investigation include: e-Vapor Product A (OTHER), e-Vapor Product B (OTHER), e-Vapor Product C (OTHER), e-Vapor Product D (OTHER).
Who is sponsoring clinical trial NCT04881942?
This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04881942's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI